icon-folder.gif   Conference Reports for NATAP  
 
  (IDRW) International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies; June 4-8, 2013; Toronto, ON, Canada Back grey_arrow_rt.gif
 
 
 
Integrase Genotypic and Phenotypic Predictors of Antiviral Response to Dolutegravir (DTG) in Subjects With Resistance to Integrase Inhibitors (INIs)
 
 
  Reported by Jules Levin
International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies; June 4-8, 2013; Toronto, ON, Canada
 
CL Vavro,1 J Huang,2 MR Underwood,1 M Ait-Khaled,3 J Sievers,3 JM Yeo3 GlaxoSmithKline, 1Research Triangle Park, NC, USA; 2Toronto, ON, Canada; 3Stockley Park, London, UK
 
ResisWksp: Analysis and Characterization of treatment-Emergent Resistance in ART-Experienced, Integrase Inhibitor-Naïve Subjects With Dolutegravir (DTG) vs Raltegravir (RAL) in SAILING (ING111762) (06/09/13)
 
ResisWksp: Epidemiology of Dolutegravir (DTG) Resistance in ~700 RAL-Resistant Isolates (06/09/13)
 

ResisWksp1.gif

ResisWksp2.gif

ResisWksp3.gif

ResisWksp4.gif

ResisWksp5.gif

ResisWksp6.gif